Teerhuis, NL
Arjan Pieter Teerhuis, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20100301571 | ACTIVE SUSPENSION ASSEMBLY FOR A VEHICLE - The invention relates to an active suspension assembly and a vehicle equipped therewith. The assembly comprises a bearing arm, spring means and adjusting means. In use, the bearing arm supports the second vehicle mass, for instance a cabin or wheel and is pivotally connected to the first vehicle mass, for instance a chassis, around a pivot axis; the spring means produce a spring force that exerts a counter moment on the bearing arm that can counterbalance any external moment acting on said bearing arm; and the adjustment means are arranged to vary said counter moment by altering the direction of the spring force and/or move its point of application in a first direction. The adjustment means are furthermore arranged to move the point of application of the spring force in a second direction, in which the counter moment is not or hardly affected, but by which the effective spring stiffness of the suspension assembly is affected. Thanks to said latter movement, the effective stiffness of the suspension can be maintained at a desired value. | 12-02-2010 |
20110187065 | MULTI-POINT HYDRAULIC SUSPENSION SYSTEM FOR A LAND VEHICLE - A multi-point hydraulic suspension system for a land vehicle has two or more individual hydraulic actuators. These two or more actuators are each operatively arranged between a suspended structure and a wheeled base of the land vehicle for relative positioning one another. A common supply of pressurized fluid has a given pressure and a selectively operable pump with an inlet and an outlet, for increasing the given pressure of the common supply of pressurized fluid. A fluid reservoir is in selective fluid communication with the inlet of the pump. Controllable valve means are interposed between each of the two or more actuators and the common supply of pressurized fluid for selectively bringing each of the two or more actuators into fluid communication with the common supply of pressurized fluid in response to a control unit for controlling the valve means and the pump. | 08-04-2011 |
20110197688 | DUMMY FOR SIMULATING HUMAN PHYSICAL BEHAVIOUR, METHOD FOR SIMULATING HUMAN PHYSICAL BEHAVIOUR - A dummy for simulating human physical behaviour during a test, comprising artificial human body elements that are mutually connected, the body elements having deformation properties, wherein a deformation property of a body element is actuatably variable. The dummy comprises an actuator for varying a deformation property. The actuator may comprise a fluidic driver. | 08-18-2011 |
Neeltje Miranda Teerhuis, Oss NL
Patent application number | Description | Published |
---|---|---|
20090221695 | Chroman Derivatives as Estrogenic Compounds - The invention provides chroman compounds having formula 1 | 09-03-2009 |
20100240748 | TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES - The present invention relates to novel tetrahydronaphthalen-2-ol derivatives, to pharmaceutical compositions comprising these compounds and to their use in therapy, in particular to their use for the manufacture of a medicament for the prevention or treatment of lower urinary tract symptoms, benign prostate hyperplasia, prostate cancer, hot flushes, anxiety, depression, breast cancer, medullary thyroid carcinoma, ovarian cancer, inflammatory bowel disease, arthritis, endometriosis, and colon cancer. | 09-23-2010 |
20110009428 | NOVEL ANDROGENS - The compounds of the subject invention have a structure according to formula I: | 01-13-2011 |
20110065768 | NON-STEROIDAL ANDROGENS COMPOUNDS - This invention provides non-steroidal compounds with affinity for the androgen receptor and utility for androgen-receptor related treatments, having a structure according to the formula | 03-17-2011 |
20110218189 | PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS - The present invention relates to a pyrrolo[2,3-d]pyrimidin-2-yl-amine derivative according to formula (I) wherein the variables are defined as in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention also relates to a pharmaceutical composition comprising one or more of said pyrrolo[2,3-d]pyrimidine-2-ylamine derivatives and to their use in therapy, for instance in the treatment of PKCθ mediated disorders. | 09-08-2011 |